In COVID-19 clinical update #65, Daniel Griffin summarizes effects of non-pharmaceutical interventions, updated summer camp guidance from CDC, serology testing not recommended by FDA, antigen tests during a music event, inhibition of vaccine immunogenicity by methotrexate, phase 3 trial results for colchicine, and small airway disease as a post-acute sequelae.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode * Effects of vaccines and NPIs (JAMA) * Guidance on summer camps (CDC) * Antibody testing not recommended (FDA) * Antigen testing at a music event (Lancet) * Methotrexate and vaccine immunogenicity (Ann Rheum Dis) * Colchicine phase 3 results (Lancet Resp Med) * Small airway disease a post-acute sequelae (medRxiv) * Letters read on TWiV 764 * Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv